ArticleTherapeutic advances in medical oncology2025
Efficacy and safety of camrelizumab plus famitinib in patients with previously treated non-small-cell lung cancer: a single-arm, phase II trial.
Ming Gao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.